News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
819,059 Results
Type
Article (75114)
Company Profile (501)
Press Release (743444)
Multimedia
Podcasts (128)
Webinars (14)
Section
Business (227556)
Career Advice (3630)
Deals (39293)
Drug Delivery (129)
Drug Development (89931)
Employer Resources (198)
FDA (17912)
Job Trends (16951)
News (388234)
Policy (38757)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56390)
ALS (100)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (159)
Approvals (17874)
Artificial intelligence (325)
Autoimmune disease (30)
Automation (16)
Bankruptcy (397)
Best Places to Work (12605)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (340)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (305)
Cancer (2454)
Cardiovascular disease (206)
Career advice (3079)
Career pathing (34)
CAR-T (174)
Cell therapy (493)
Cervical cancer (22)
Clinical research (72627)
Collaboration (919)
Company closure (1)
Compensation (571)
Complete response letters (30)
COVID-19 (2867)
CRISPR (48)
C-suite (269)
Cystic fibrosis (108)
Data (2296)
Decentralized trials (2)
Denatured (45)
Depression (55)
Diabetes (301)
Diagnostics (6917)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (147)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (93854)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (128137)
Executive appointments (781)
FDA (19269)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (820)
Gene editing (121)
Generative AI (34)
Gene therapy (360)
GLP-1 (856)
Government (5141)
Grass and pollen (6)
Guidances (84)
Healthcare (20875)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (58)
Intellectual property (101)
Interviews (770)
IPO (17742)
IRA (51)
Job creations (4809)
Job search strategy (2468)
Kidney cancer (11)
Labor market (42)
Layoffs (555)
Leadership (24)
Legal (9859)
Liver cancer (82)
Lung cancer (346)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (358)
MASH (76)
Medical device (14599)
Medtech (14604)
Mergers & acquisitions (22109)
Metabolic disorders (796)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2111)
NextGen: Class of 2025 (7555)
Non-profit (5079)
Now hiring (40)
Obesity (428)
Opinion (275)
Ovarian cancer (79)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (161)
Partnered (21)
Patents (254)
Patient recruitment (117)
Peanut (51)
People (63838)
Pharmaceutical (108)
Pharmacy benefit managers (21)
Phase I (22499)
Phase II (31646)
Phase III (23788)
Pipeline (1285)
Policy (174)
Postmarket research (3310)
Preclinical (10024)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7185)
Recruiting (75)
Regulatory (26094)
Reports (57)
Research institute (2651)
Resumes & cover letters (564)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (93)
Service/supplier (24)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (4220)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (49)
The Weekly (81)
Vaccines (815)
Venture capitalists (44)
Weight loss (304)
Women's health (40)
Worklife (20)
Date
Today (126)
Last 7 days (835)
Last 30 days (2932)
Last 365 days (35442)
2025 (12086)
2024 (37897)
2023 (42559)
2022 (53921)
2021 (58715)
2020 (57648)
2019 (51310)
2018 (39083)
2017 (36687)
2016 (37450)
2015 (43498)
2014 (38110)
2013 (34252)
2012 (36455)
2011 (36613)
2010 (36331)
Location
Africa (1167)
Alabama (59)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (48447)
Australia (8313)
California (6474)
Canada (2078)
China (568)
Colorado (283)
Connecticut (300)
Delaware (159)
Europe (109340)
Florida (946)
Georgia (220)
Hawaii (1)
Idaho (64)
Illinois (626)
India (30)
Indiana (336)
Iowa (11)
Japan (173)
Kansas (110)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (968)
Massachusetts (4946)
Michigan (249)
Minnesota (422)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1834)
New Mexico (31)
New York (1838)
North Carolina (1120)
North Dakota (9)
Northern California (2788)
Ohio (218)
Oklahoma (15)
Oregon (43)
Pennsylvania (1429)
Puerto Rico (13)
Rhode Island (35)
South America (1562)
South Carolina (24)
South Dakota (1)
Southern California (2413)
Tennessee (105)
Texas (965)
United States (24813)
Utah (194)
Virginia (167)
Washington D.C. (71)
Washington State (594)
West Virginia (3)
Wisconsin (68)
819,059 Results for "berlex biosciences acquired by bayer ag in 2006".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Castle Biosciences to Acquire Previse
May 6, 2025
·
4 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
China
Bayer Jumps on Chinese Partnership Train with Oncology Deal
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.
March 26, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right
May 1, 2025
·
6 min read
Press Releases
Bayer Initiates Phase I Study Targeting GPC3 With Actinium-225 Radiopharmaceutical in Patients With Advanced Hepatocellular Carcinoma
April 29, 2025
·
6 min read
Business
Bayer AG Enters Into Agreement With TetraScience to Ignite Innovation by Maximizing the Value of Its Scientific Data
Bayer AG (BAYRY), a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, today announced an agreement aimed at maximizing the value of scientific data and driving innovation.
February 5, 2024
·
3 min read
Press Releases
Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies
January 10, 2025
·
7 min read
Startups
Roivant Creates New ‘Vant’ to License Bayer’s Pulmonary Hypertension Drug
Under an in-license agreement worth up to $294 million, Roivant Sciences gains exclusive worldwide rights from Bayer to develop and commercialize mosliciguat, a potential first-in-class inhaled soluble guanylate cyclase activator.
September 10, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Court Certifies National Class Action Against Monsanto and Bayer Over Alleged Link Between Roundup® and Non-Hodgkin’s Lymphoma
April 21, 2025
·
2 min read
Clinical research
Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%
Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.
September 3, 2024
·
2 min read
·
Annalee Armstrong
1 of 81,906
Next
